ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

ECB. 2020; 9(9): 285-290


EVALUATION OF ANTIOXIDATIVE, ANTIMICROBIAL AND CYTOTOXIC ACTIVITY OF THE SYNTHETIZED ARYLMETHYLENBIS(3-HYDROXY-5,5-DIMETHYL-2- CYCLOHEXEN-1-ONE) DERIVATIVES

A. Džambić, S. Muratović, E. Veljović, A. Softić, E. Dautović, M. Šljivić Husejnović, E. Horozić, A. Smajlović.



Abstract
Download PDF Post

Arylmethylenebis(3-hydroxy-5,5-dimethyl-2-cyclohexen-1-one) derivatives (aryl=2-hydroxynaphthyl (1) and 3,4-dihydroxyphenyl (2) have been synthesized and their structures have been elucidated. Both compounds were examined for their antioxidant, antimicrobial and cytotoxic activity. Antioxidative activities of synthesized compounds were evaluated by 2,2-diphenyl-1-picryl-hydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) methods. The microbial screening was performed by diffusion method on bacterial strains Staphylococcus aureus, Enterococcus faecalis, Bacillus subtilis and Candida albicans. Cytotoxic activity was tested on liver hepatocellular carcinoma cell line (Hep G2) by Neutral red assay. Compared to compound 2, compound 1 showed better antimicrobial and antifungal activity, while compound 2 showed better antioxidant activity with IC50 of 0.0156 mM and FRAP value 50469.44 µmol/l Fe2+. Both compounds showed cytotoxic activity. Obtained results implicate the importance of arylmethylenebis(3-hydroxy-5,5-dimethyl-2-cyclohexen-1-on) derivatives as a potential antioxidant, antimicrobial and cytotoxic agents.

Key words: Tetraketones; cyclohexen-1-one derivatives; synthesis; antioxidants; antimicrobial screening; cytotoxic activity.





Bibliomed Article Statistics

33
31
42
25
35
52
29
24
27
38
34
18
R
E
A
D
S

22

27

83

21

22

45

18

24

18

20

22

13
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.